FLT3 and acute myeloid leukemia: Therefore, the MOLM-13 and the MV4-11 have been used as research models to understand the mechanisms underlying FLT3-ITD positive AML maintenance and drug resistance to tyrosine kinase inhibitors (TKI) treatment.